Emmaus Life Sciences, Inc. Annual Current Federal Tax Expense (Benefit) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Current Federal Tax Expense (Benefit) history and growth rate from 2018 to 2022.
  • Emmaus Life Sciences, Inc. Current Federal Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Emmaus Life Sciences, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $30K, a 20% increase from 2021.
  • Emmaus Life Sciences, Inc. annual Current Federal Tax Expense (Benefit) for 2021 was $25K, a 45.7% decline from 2020.
  • Emmaus Life Sciences, Inc. annual Current Federal Tax Expense (Benefit) for 2020 was $46K, a 72% decline from 2019.
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $30K +$5K +20% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $25K -$21K -45.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $46K -$118K -72% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $164K +$126K +332% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-08-10
2018 $38K Jan 1, 2018 Dec 31, 2018 10-K 2021-01-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.